Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study

• DOI: 10.1111/jir.12685
• Publication Date: 2019-09-03T05:03:40Z
• Authors: M. Song; R. Ware; T. N. Doan; D. Harley
• Keywords: Psychotropic medication; Longitudinal Study; Psychotropic drug; Pharmacoepidemiology

Abstract Background Longitudinal data on medication use in adults with intellectual disability (ID) are scarce. We describe the longitudinal of and factors associated psychotropic prescribing ID living Australian community. Methods were obtained from community Queensland, Australia, between 1999 2015. Participant characteristics information extracted baseline questionnaires health check booklets. Logistic regression was used to investigate associations participant use, commencement or cessation. Results available for 138 participants 697 reviews. The proportion prescribed medications increased 43% 54% rates cessation consecutive time periods ranged 9% 18% 7% 15%, respectively. Challenging behaviour (adjusted odds ratio = 4.1; 95% confidence interval: 2.1–7.9). Presence challenging behaviour, either consistent newly identified, positively ongoing medications. Conclusions Psychotropic commonly ID. is commencement.